San Martin Quoted in Life Sciences Intellectual Property Review on UK Supreme Court Drug Patent Decision

Intellectual Property partner Dr. Beatriz San Martin was quoted in a Life Sciences Intellectual Property Review article, "UK Supreme Court Shoots Down NHS £220m Drug Patent Suit." The article discusses a recent ruling by the UK Supreme Court that the British government cannot avail itself of the tort of unlawful means in its £220 million damages claim against an international pharmaceutical company for allegedly misrepresenting its blood pressure drugs patent in legal proceedings to block generic competitors from entering the market.

» Read the full article (subscription required).